Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microfluidic Biosensors for Diagnostic Devices Faster and Cheaper

By HospiMedica staff writers
Posted on 23 Apr 2007
A faster and lower cost microfluidic biosensor platform is being developed for R&D laboratories.

Universal Sensors of Cambridge, which is contracted by Sensortec (Cambridge, UK) to carry out all R&D on its proprietary biosensor technology, is working with Minifab (Melbourne, Australia) on the development and marketing of the microfluidic biosensor development platform. More...
The collaboration will allow other developers to build upon this expertise to transfer their assays onto polymer microfluidic biosensor platforms, allowing development of point-of-use diagnostic devices.

Sensortec technology provides a universally applicable electrochemical biosensor suitable for a whole range of diagnostic tests and other quantitative receptor-target binding assays requiring high analytic sensitivity. This biosensor technology has multiple applications and has already been evaluated for use in the environmental and food quality assurance sectors for detecting such contaminants as mycotoxins and drug residues.

Using micro- and nano-engineering, the MiniChemLab family of systems is an integrated platform to be used by biosensor assay developers wishing to optimize system specifications to realize commercial point-of-use diagnostic instrumentation.

Minifab CEO, Erol Harvey, said, "We have been impressed at the robustness and great sensitivity of the low cost biosensor technology. The simplicity of the electrochemical sensor easily allows it to be integrated into our polymer microfluidic systems.”

Commenting on why Sensortec has chosen Minifab to work with, Duncan Purvis stated, "Minifab has a well demonstrated rapid-prototyping technology for polymer microfluidics which easily translates into low-cost high-volume production.”


Related Links:
Sensortec
Minifab

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.